rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-3-22
|
pubmed:abstractText |
A clinical trial of cyclosporine in patients with steroid-resistant membranous nephropathy (MGN) was conducted. Although MGN remains the most common cause of adult-onset nephrotic syndrome, its management is still controversial. Cyclosporine has been shown to be effective in cases of progressive MGN, but it has not been used in controlled studies at an early stage of the disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0085-2538
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1484-90
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11260412-Adult,
pubmed-meshheading:11260412-Cyclosporine,
pubmed-meshheading:11260412-Dose-Response Relationship, Drug,
pubmed-meshheading:11260412-Drug Resistance,
pubmed-meshheading:11260412-Drug Therapy, Combination,
pubmed-meshheading:11260412-Female,
pubmed-meshheading:11260412-Glomerulonephritis, Membranous,
pubmed-meshheading:11260412-Glucocorticoids,
pubmed-meshheading:11260412-Humans,
pubmed-meshheading:11260412-Immunosuppressive Agents,
pubmed-meshheading:11260412-Male,
pubmed-meshheading:11260412-Middle Aged,
pubmed-meshheading:11260412-Prednisone,
pubmed-meshheading:11260412-Prospective Studies,
pubmed-meshheading:11260412-Proteinuria,
pubmed-meshheading:11260412-Recurrence,
pubmed-meshheading:11260412-Retreatment,
pubmed-meshheading:11260412-Single-Blind Method,
pubmed-meshheading:11260412-Steroids,
pubmed-meshheading:11260412-Treatment Outcome
|
pubmed:year |
2001
|
pubmed:articleTitle |
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
|
pubmed:affiliation |
Department of Medicine, University of Toronto, Toronto, Ontario, Canada. daniel.catran@uhn.on.ca
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|